Verity Saunders

  • 1365 Citations
  • 14 h-Index
20052019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

My role as Laboratory Manager is to oversee the operations of the Precision Medicine Theme North PC2 Laboratory to ensure it is a functional and harmonious working environment for our researchers. As a Clinical Research Scientist, I am involved in the processing of haematopoietic samples collected on various CML clinical trial protocols (e.g. trials assessing efficacy of tyrosine kinase inhibitor (TKI) therapy, or more recently, trials of TKI cessation). I perform Correlative Science Studies for these trials, data entry and analysis, result verification and manage our extensive CML tissue-bank and cryo-bank to safeguard specimens for future research. Additionally, I am involved with a number of research projects (Treatment-free Remission in CML; ABL001 - a new allosteric inhibitor of Bcr-Abl), assist post-doctoral researchers and contribute to manuscripts for scientific publication.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 1365 Citations
  • 14 h-Index
  • 20 Article
  • 7 Letter

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Ross, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e56-e60

Research output: Contribution to journalLetter

5 Citations (Scopus)

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Pagani, I. S., Dang, P., Kommers, I. O., Goyne, J. M., Nicola, M., Saunders, V. A., Braley, J., White, D. L., Yeung, D. T., Branford, S., Hughes, T. P. & Ross, D. M., 30 Nov 2018, In : Haematologica. 103, 12, p. 2026-2032 7 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 1 Dec 2018, In : Leukemia. 32, 12, p. 2572-2579 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression in vitro

Eadie, L., Saunders, V., Branford, S., White, D. & Hughes, T., 1 Jan 2018, In : Oncotarget. 9, 17, p. 13423-13437 15 p.

Research output: Contribution to journalArticle